Schedule 13D ownership disclosure

Arcturus Therapeutics Holdings Inc

Security class unavailable · CUSIP: 03969T109

Event date: 2020-12-08

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
9.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-20-314963
Form type
SC 13D/A
Filer
Arcturus Therapeutics Holdings Inc.
CIK
CIK 1768224
Filed
Dec 10, 2020
Reporting period
Dec 08, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub